Joseph Talamo

CIK 1524547 · Chief Financial Officer · last filed 2026-01-05

Joseph Talamo is a Chief Financial Officer who has filed 30 SEC Form 4 insider transactions across 4 companies since 2011. The most recent filing shows the insider was granted $3.8K of INTS on Jan 5, 2026. Current disclosed insider exposure totals $103.8K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$103.8K

Companies

4

Total Filings

30

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
INTS Chief Financial Officer 28,661 $3.62 $103.8K $0 5 2026-01-05
LISATA THERAPEUTICS, INC. (CLBS) Delisted SVP and CFO 59,644 $6.40 $381.5K $0 17 2020-01-15
LISATA THERAPEUTICS, INC. (NBS) Delisted Chief Accounting Officer 30,839 $0 6 2015-06-04
LISATA THERAPEUTICS, INC. (NBS.WS) Delisted See Remarks $0 2 2012-01-06

Recent Filings

30 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-01-05 INTS Grant (A) +14,482 $3.8K EDGAR
2025-07-02 INTS Grant (A) +14,179 $3.7K EDGAR
2025-05-06 INTS Grant (A) $0 EDGAR
2024-10-23 INTS Grant (A) $0 EDGAR
2023-12-12 INTS Grant (A) $0 EDGAR
2020-01-15 LISATA THERAPEUTICS, INC. (CLBS) Delisted Mixed +14,209 -$15.9K EDGAR
2020-01-09 LISATA THERAPEUTICS, INC. (CLBS) Delisted Tax (F) −1,821 -$5.2K EDGAR
2019-01-16 LISATA THERAPEUTICS, INC. (CLBS) Delisted Mixed +13,841 $0 EDGAR
2019-01-10 LISATA THERAPEUTICS, INC. (CLBS) Delisted Tax (F) −1,795 -$8.3K EDGAR
2018-06-21 LISATA THERAPEUTICS, INC. (CLBS) Delisted Mixed +6,893 $59.6K EDGAR
Showing 110 of 30
Page 1 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.